Provided by Tiger Trade Technology Pte. Ltd.

Cohen & Steers

83.16
+1.742.14%
Pre-market: 83.340.1800+0.22%05:46 EDT
Volume:287.76K
Turnover:23.82M
Market Cap:4.27B
PE:25.58
High:83.56
Open:81.99
Low:79.55
Close:81.42
52wk High:86.56
52wk Low:58.39
Shares:51.39M
Float Shares:27.75M
Volume Ratio:1.22
T/O Rate:1.04%
Dividend:2.58
Dividend Rate:3.10%
EPS(TTM):3.25
EPS(LYR):2.97
ROE:27.33%
ROA:14.54%
PB:7.25
PE(LYR):28.00

Loading ...

Cohen & Steers Names Erik Schneberger Chief Marketing Officer

Reuters
·
Jul 20

Cohen & Steers Appoints Erik Schneberger as Chief Marketing Officer

THOMSON REUTERS
·
Jul 20

Cohen & Steers Q2 Earnings Call Highlights Momentum

TIPRANKS
·
Jul 18

Earnings Flash (CNS) Cohen & Steers Posts Q2 Adjusted EPS $0.85, vs. FactSet Est of $0.86

MT Newswires Live
·
Jul 17

Cohen & Steers Q2 Assets Under Management USD 100,100 Million

THOMSON REUTERS
·
Jul 17

Cohen & Steers Reports Results for Second Quarter 2026

THOMSON REUTERS
·
Jul 17

Press Release: COHEN & Steers Reports Results for Second Quarter 2026

Dow Jones
·
Jul 17

Cohen & Steers Q2 FY26 Adjusted EPS Rises 16.44% to $0.85; AUM Increases 7.5% to $100.1 Billion

Reuters
·
Jul 17

Cohen & Steers Q2 FY26 Diluted EPS Rises 15.85% to $0.95; Revenue Increases 4.88% to $152.7 Million

Reuters
·
Jul 17

U.S. Earnings Preview: After Market Close July 16

Dow Jones
·
Jul 17

Cohen & Steers RQI Fund Expects to Issue 12,642,989 Shares in Rights Offering Priced at $12.15 Each

Reuters
·
Jul 16

Cohen & Steers Quality Income Realty Fund, Inc. Announces Preliminary Results of Transferable Rights Offering

THOMSON REUTERS
·
Jul 16

Top News Today: Megacap Tech Names Lift U.S. Stock Indexes

Dow Jones
·
Jul 16

Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models

GlobeNewswire
·
Jul 15

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

GlobeNewswire
·
Jul 15

Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers

GlobeNewswire
·
Jul 15

Is Axsome Therapeutics (AXSM) Reframing Its CNS Strategy With Pediatric Solriamfetol Trial Expansion?

Simply Wall St.
·
Jul 14

Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD

GlobeNewswire
·
Jul 14

Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10

GlobeNewswire
·
Jul 14

Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026

GlobeNewswire
·
Jul 13